Sight Sciences OMNI Surgical System to Be Featured in Multiple Presentations at the 2022 ESCRS

Sight Sciences announced that its OMNI Surgical System will be featured in seven clinical presentations at the 2022 European Society of Cataract & Refractive Surgeons (ESCRS) meeting in Milan, Italy from September 16-20. 

At Sight Sciences Booth A22 in Hall 4 at the Milano Convention Centre, ESCRS attendees will also have the opportunity to engage in peer-to-peer discussions with four glaucoma physicians and participate in hands-on demonstrations with the OMNI Surgical System—an implant-free procedure that uniquely addresses all three known points of resistance in the aqueous outflow system: the trabecular meshwork, Schlemm’s canal and the collector channels.

“Globally, there are significant drawbacks associated with eye drop-based glaucoma polypharmacy in terms of both cost to the health care system and poor patient compliance,” Paul Badawi, CEO and co-founder of Sight Sciences, said in a company news release. “We are honored to witness the growing adoption of the OMNI Surgical System in both combination cataract procedures as well as in standalone use.”

Poster Presentations

1. Intraocular Pressure (IOP) Fluctuations and Visual Field Status: Fluctuation Suppression with Combined Canaloplasty and Trabeculotomy in Open-Angle Glaucoma (OAG) by Michael Greenwood, MD
2. Outcomes Of Canaloplasty and Trabeculotomy in Glaucomatous Eyes with Previous Trabecular Micro-Bypass Implantation and Uncontrolled on Medication by Daniel Terveen, MD; Michael Greenwood, MD
3. A Prospective, 36-Month Evaluation of Subjects with Mild to Moderate Open-Angle Glaucoma Treated with the OMNI Surgical System as Standalone Procedure by Karsten Klabe, MD; Andreas Fricke, MD
4. Omni Surgical System: Preliminary Results from a Systematic Review Evaluating the Treatment of Open-Angle Glaucoma by Dan Lindfield, MD
5. Long Term Effect of Ab-Interno Canaloplasty with or without Cataract Extraction (CE) on Intraocular Pressure (IOP) and Use of IOP Lowering Medications in Patients with Open-Angle Glaucoma (OAG) by Simon Ondrejka, Norbert Koerber
6. Real World Evaluation of Canaloplasty and Trabeculotomy Combined with Cataract Surgery in Open-Angle Glaucoma (OAG): A Retrospective, Multicenter, 12 Month Study (ROMEO II) by James Murphy, MD
7. OMNI in Open-Angle Glaucoma Treatment: A 42-Month Interim Follow-Up by Iwona Grabska-Liberek, MD, PhD; Anna M. Koziorowska, MD; Joanna Wereszczyńska, MD; Julita Majszyk-Ionescu, MD

OMNI Experts at ESCRS (Booth A22/Hall 4) 

Friday, September 16, 2022

• 15:30-16:30: Andrew Tatham, MD, MBA, FRCOphth, FEBO, CertLRS of Princess Alexandra Eye Pavilion of Edinburgh, United Kingdom
• 16:30 - 17:15: Ike Ahmed, MD, John A. Moran Eye Center, Utah, United States

Saturday, September 17, 2022

• 12:00 - 13:00: Dan Lindfield, MD, PGCME FRCOphth, Royal Surrey County Hospital Guildford, United Kingdom
• 14:00 - 15:00: Karsten Klabe, MD, Breyer, Kaymak & Klabe Augenchirurgie Düsseldorf, Germany

Dr. Tatham, Dr. Ahmed, Dr. Lindfield, and Dr. Klabe are paid consultants of Sight Sciences.